Hudson Bay Capital Management LP Cyma Bay Therapeutics, Inc. Transaction History

Hudson Bay Capital Management LP

$18.6 Billion
Q2 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$12.63 - $24.47 $694,650 - $1.35 Million	55,000 Added 183.33%	85,000 $2.01 Million
Q3 2023 Nov 14, 2023	BUY	$10.86 - $17.62 $325,800 - $528,600	30,000 New	30,000 $447,000
Q1 2023 May 16, 2023	BUY	$5.88 - $9.59 $309,452 - $504,702	52,628 Added 24.62%	266,400 $2.32 Million
Q1 2023 May 15, 2023	SELL	$5.88 - $9.59 $2.84 Million - $4.64 Million	-483,728 Reduced 69.35%	213,772 $1.86 Million
Q4 2022 Feb 14, 2023	SELL	$3.22 - $6.27 $2.02 Million - $3.93 Million	-627,500 Reduced 47.36%	697,500 $4.37 Million
Q3 2022 Nov 14, 2022	SELL	$2.77 - $4.25 $484,473 - $743,325	-174,900 Reduced 11.66%	1,325,000 $4.64 Million
Q2 2022 Aug 12, 2022	BUY	$1.72 - $3.39 $1.23 Million - $2.42 Million	714,900 Added 91.07%	1,499,900 $4.43 Million
Q1 2022 May 16, 2022	BUY	$2.77 - $3.64 $373,950 - $491,400	135,000 Added 20.77%	785,000 $2.44 Million
Q4 2021 Feb 14, 2022	BUY	$3.23 - $4.6 $871,932 - $1.24 Million	269,948 Added 71.03%	650,000 $2.2 Million
Q3 2021 Nov 15, 2021	BUY	$3.47 - $4.42 $277,780 - $353,829	80,052 Added 26.68%	380,052 $1.39 Million
Q2 2021 Aug 16, 2021	BUY	$3.94 - $4.92 $374,300 - $467,400	95,000 Added 46.34%	300,000 $1.31 Million
Q1 2021 May 14, 2021	BUY	$4.23 - $6.55 $474,779 - $735,178	112,241 Added 121.0%	205,000 $931,000
Q4 2020 Feb 12, 2021	BUY	$5.73 - $9.03 $531,509 - $837,613	92,759 New	92,759 $532,000
Q3 2020 Nov 12, 2020	SELL	$3.32 - $7.24 $1.11 Million - $2.43 Million	-335,000 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$1.41 - $4.25 $169,200 - $510,000	120,000 Added 55.81%	335,000 $1.17 Million
Q1 2020 May 14, 2020	SELL	$1.25 - $2.02 $137,500 - $222,200	-110,000 Reduced 33.85%	215,000 $318,000
Q4 2019 Feb 12, 2020	BUY	$1.33 - $5.93 $432,250 - $1.93 Million	325,000 New	325,000 $637,000
Q3 2019 Nov 13, 2019	SELL	$5.12 - $7.21 $71,680 - $100,940	-14,000 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$6.05 - $13.66 $84,700 - $191,240	14,000 New	14,000 $100,000

Others Institutions Holding CBAY

# of Institutions

Shares Held

1.82M

Call Options Held

Put Options Held

View Full List

About CymaBay Therapeutics, Inc.

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

More about CBAY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hudson Bay Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Hudson Bay Capital Management LP with notifications on news.

Account